[96a5a0]: / output / chiaCancer / identified / NCT01757717_identified.json

Download this file

451 lines (451 with data), 19.3 kB

  1
  2
  3
  4
  5
  6
  7
  8
  9
 10
 11
 12
 13
 14
 15
 16
 17
 18
 19
 20
 21
 22
 23
 24
 25
 26
 27
 28
 29
 30
 31
 32
 33
 34
 35
 36
 37
 38
 39
 40
 41
 42
 43
 44
 45
 46
 47
 48
 49
 50
 51
 52
 53
 54
 55
 56
 57
 58
 59
 60
 61
 62
 63
 64
 65
 66
 67
 68
 69
 70
 71
 72
 73
 74
 75
 76
 77
 78
 79
 80
 81
 82
 83
 84
 85
 86
 87
 88
 89
 90
 91
 92
 93
 94
 95
 96
 97
 98
 99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
121
122
123
124
125
126
127
128
129
130
131
132
133
134
135
136
137
138
139
140
141
142
143
144
145
146
147
148
149
150
151
152
153
154
155
156
157
158
159
160
161
162
163
164
165
166
167
168
169
170
171
172
173
174
175
176
177
178
179
180
181
182
183
184
185
186
187
188
189
190
191
192
193
194
195
196
197
198
199
200
201
202
203
204
205
206
207
208
209
210
211
212
213
214
215
216
217
218
219
220
221
222
223
224
225
226
227
228
229
230
231
232
233
234
235
236
237
238
239
240
241
242
243
244
245
246
247
248
249
250
251
252
253
254
255
256
257
258
259
260
261
262
263
264
265
266
267
268
269
270
271
272
273
274
275
276
277
278
279
280
281
282
283
284
285
286
287
288
289
290
291
292
293
294
295
296
297
298
299
300
301
302
303
304
305
306
307
308
309
310
311
312
313
314
315
316
317
318
319
320
321
322
323
324
325
326
327
328
329
330
331
332
333
334
335
336
337
338
339
340
341
342
343
344
345
346
347
348
349
350
351
352
353
354
355
356
357
358
359
360
361
362
363
364
365
366
367
368
369
370
371
372
373
374
375
376
377
378
379
380
381
382
383
384
385
386
387
388
389
390
391
392
393
394
395
396
397
398
399
400
401
402
403
404
405
406
407
408
409
410
411
412
413
414
415
416
417
418
419
420
421
422
423
424
425
426
427
428
429
430
431
432
433
434
435
436
437
438
439
440
441
442
443
444
445
446
447
448
449
450
451
{
"info": {
"nct_id": "NCT01757717",
"official_title": "A Pilot Study of Image-Guided Navigation for High Dose Rate Temporary Interstitial Brachytherapy in the Palliative Management of Previously Treated Tumors of the Spine and Pelvis",
"inclusion_criteria": "* Patients must have histologic proof of a malignancy suitable for radiation therapy.\n* Patients must have received prior external beam radiation therapy to the region proposed for HDR brachytherapy treatment; evaluation of doses previously delivered to spinal cord/cauda equine, pelvis, and other critical structures (bowel, kidneys, rectum) will be taken into consideration.\n* If repeat irradiation would exceed any normal tissue constraint set by MSKCC Radiation Oncology Department dose constraint criteria, the patient will potentially be eligible.\n* If the total prior radiation dose to the cord or pelvis exceeds 100 Gy BED equivalent, the patient will be potentially eligible, where a total of 100 BED Gy equivalent is determined by the biological equivalent dose (BED) calculation; BED = nd(1 + d/α/β), where n = number of fractions and d = dose per fraction; α/β is the constant for spinal cord late effect and equals 2. [Rades 2005, Nieder 2005, Sahgal 2012]\n* KPS ≥ 60\n* Age ≥ 18 years old\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
"exclusion_criteria": "* Patients who may receive therapeutically effective doses via an external beam approach to the lesion of interest as specified by MSKCC Radiation Oncology Department dose constraint criteria.\n* Patients with kyphoplasty cement or hardware that would preclude effective catheter placement.\n* Patients with paraspinal extension of disease with visceral involvement.\n* Abnormal complete blood count. Any of the following:\n* Platelet count < 75,000/ml\n* Hb level < 9gm/dl\n* WBC < 3.5/ml\n* Abnormal coagulation profile: INR > 2.5 and/or PTT > 80\n* Patients who are on anticoagulation medication that may not be safely held for the procedure (≥ 5 days for antiplatelet agents and warfarin; ≥ 24 hours for low-molecular weight heparin formulations) will be excluded.\n* Contraindications to general anesthesia",
"miscellaneous_criteria": ""
},
"inclusion_lines": [
{
"line": "* Patients must have histologic proof of a malignancy suitable for radiation therapy.",
"criterions": [
{
"exact_snippets": [
"histologic proof of a malignancy"
],
"criterion": "malignancy",
"requirement_type": "histologic proof",
"expected_value": true
},
{
"exact_snippets": [
"suitable for radiation therapy"
],
"criterion": "malignancy",
"requirement_type": "suitability for radiation therapy",
"expected_value": true
}
]
},
{
"line": "* Patients must have received prior external beam radiation therapy to the region proposed for HDR brachytherapy treatment; evaluation of doses previously delivered to spinal cord/cauda equine, pelvis, and other critical structures (bowel, kidneys, rectum) will be taken into consideration.",
"criterions": [
{
"exact_snippets": [
"Patients must have received prior external beam radiation therapy"
],
"criterion": "external beam radiation therapy",
"requirement_type": "prior treatment",
"expected_value": true
},
{
"exact_snippets": [
"evaluation of doses previously delivered to spinal cord/cauda equine"
],
"criterion": "doses previously delivered to spinal cord/cauda equine",
"requirement_type": "evaluation",
"expected_value": "consideration"
},
{
"exact_snippets": [
"evaluation of doses previously delivered to",
"pelvis"
],
"criterion": "doses previously delivered to pelvis",
"requirement_type": "evaluation",
"expected_value": "consideration"
},
{
"exact_snippets": [
"evaluation of doses previously delivered to",
"other critical structures (bowel, kidneys, rectum)"
],
"criterion": "doses previously delivered to other critical structures",
"requirement_type": "evaluation",
"expected_value": "consideration"
}
]
},
{
"line": "* If repeat irradiation would exceed any normal tissue constraint set by MSKCC Radiation Oncology Department dose constraint criteria, the patient will potentially be eligible.",
"criterions": [
{
"exact_snippets": [
"repeat irradiation would exceed any normal tissue constraint"
],
"criterion": "normal tissue constraint",
"requirement_type": "exceedance",
"expected_value": true
},
{
"exact_snippets": [
"set by MSKCC Radiation Oncology Department dose constraint criteria"
],
"criterion": "dose constraint criteria",
"requirement_type": "source",
"expected_value": "MSKCC Radiation Oncology Department"
}
]
},
{
"line": "* If the total prior radiation dose to the cord or pelvis exceeds 100 Gy BED equivalent, the patient will be potentially eligible, where a total of 100 BED Gy equivalent is determined by the biological equivalent dose (BED) calculation; BED = nd(1 + d/α/β), where n = number of fractions and d = dose per fraction; α/β is the constant for spinal cord late effect and equals 2. [Rades 2005, Nieder 2005, Sahgal 2012]",
"criterions": [
{
"exact_snippets": [
"total prior radiation dose to the cord or pelvis"
],
"criterion": "prior radiation dose",
"requirement_type": "location",
"expected_value": [
"cord",
"pelvis"
]
},
{
"exact_snippets": [
"total prior radiation dose to the cord or pelvis exceeds 100 Gy BED equivalent"
],
"criterion": "prior radiation dose",
"requirement_type": "quantity",
"expected_value": {
"comparisons": [
{
"operator": ">",
"value": 100
}
]
}
}
]
},
{
"line": "* KPS ≥ 60",
"criterions": [
{
"exact_snippets": [
"KPS ≥ 60"
],
"criterion": "Karnofsky Performance Status (KPS)",
"requirement_type": "minimum value",
"expected_value": {
"operator": ">=",
"value": 60
}
}
]
},
{
"line": "* Age ≥ 18 years old",
"criterions": [
{
"exact_snippets": [
"Age ≥ 18 years old"
],
"criterion": "age",
"requirement_type": "N/A",
"expected_value": {
"comparisons": [
{
"operator": ">=",
"value": 18
}
]
}
}
]
},
{
"line": "Healthy volunteers allowed",
"criterions": [
{
"exact_snippets": [
"Healthy volunteers allowed"
],
"criterion": "healthy volunteers",
"requirement_type": "participation",
"expected_value": true
}
]
},
{
"line": "Must have minimum age of 18 Years",
"criterions": [
{
"exact_snippets": [
"minimum age of 18 Years"
],
"criterion": "age",
"requirement_type": "minimum",
"expected_value": {
"operator": ">=",
"value": 18
}
}
]
}
],
"exclusion_lines": [
{
"line": "* Patients who may receive therapeutically effective doses via an external beam approach to the lesion of interest as specified by MSKCC Radiation Oncology Department dose constraint criteria.",
"criterions": [
{
"exact_snippets": [
"therapeutically effective doses"
],
"criterion": "dose",
"requirement_type": "effectiveness",
"expected_value": "therapeutically effective"
},
{
"exact_snippets": [
"external beam approach"
],
"criterion": "treatment approach",
"requirement_type": "type",
"expected_value": "external beam"
},
{
"exact_snippets": [
"lesion of interest"
],
"criterion": "lesion",
"requirement_type": "interest",
"expected_value": true
},
{
"exact_snippets": [
"MSKCC Radiation Oncology Department dose constraint criteria"
],
"criterion": "dose constraint criteria",
"requirement_type": "source",
"expected_value": "MSKCC Radiation Oncology Department"
}
]
},
{
"line": "* Patients with kyphoplasty cement or hardware that would preclude effective catheter placement.",
"criterions": [
{
"exact_snippets": [
"kyphoplasty cement"
],
"criterion": "kyphoplasty cement",
"requirement_type": "presence",
"expected_value": true
},
{
"exact_snippets": [
"hardware that would preclude effective catheter placement"
],
"criterion": "hardware",
"requirement_type": "impact on catheter placement",
"expected_value": "preclude effective placement"
}
]
},
{
"line": "* Patients with paraspinal extension of disease with visceral involvement.",
"criterions": [
{
"exact_snippets": [
"paraspinal extension of disease"
],
"criterion": "paraspinal extension",
"requirement_type": "presence",
"expected_value": true
},
{
"exact_snippets": [
"visceral involvement"
],
"criterion": "visceral involvement",
"requirement_type": "presence",
"expected_value": true
}
]
},
{
"line": "* Abnormal complete blood count. Any of the following:",
"criterions": [
{
"exact_snippets": [
"Abnormal complete blood count"
],
"criterion": "complete blood count",
"requirement_type": "normality",
"expected_value": false
}
]
},
{
"line": "* Platelet count < 75,000/ml",
"criterions": [
{
"exact_snippets": [
"Platelet count < 75,000/ml"
],
"criterion": "platelet",
"requirement_type": "count",
"expected_value": {
"comparisons": [
{
"operator": "<",
"value": 75000
}
]
}
}
]
},
{
"line": "* Hb level < 9gm/dl",
"criterions": [
{
"exact_snippets": [
"Hb level < 9gm/dl"
],
"criterion": "Hb level",
"requirement_type": "quantity",
"expected_value": {
"comparisons": [
{
"operator": "<",
"value": 9
}
]
}
}
]
},
{
"line": "* WBC < 3.5/ml",
"criterions": [
{
"exact_snippets": [
"WBC < 3.5/ml"
],
"criterion": "white blood cell",
"requirement_type": "count",
"expected_value": {
"operator": "<",
"value": 3.5
}
}
]
},
{
"line": "* Abnormal coagulation profile: INR > 2.5 and/or PTT > 80",
"criterions": [
{
"exact_snippets": [
"Abnormal coagulation profile",
"INR > 2.5"
],
"criterion": "INR",
"requirement_type": "value",
"expected_value": {
"operator": ">",
"value": 2.5
}
},
{
"exact_snippets": [
"Abnormal coagulation profile",
"PTT > 80"
],
"criterion": "PTT",
"requirement_type": "value",
"expected_value": {
"operator": ">",
"value": 80
}
}
]
},
{
"line": "* Patients who are on anticoagulation medication that may not be safely held for the procedure (≥ 5 days for antiplatelet agents and warfarin; ≥ 24 hours for low-molecular weight heparin formulations) will be excluded.",
"criterions": [
{
"exact_snippets": [
"Patients who are on anticoagulation medication"
],
"criterion": "anticoagulation medication",
"requirement_type": "usage",
"expected_value": true
},
{
"exact_snippets": [
"may not be safely held for the procedure"
],
"criterion": "anticoagulation medication",
"requirement_type": "safety of holding",
"expected_value": false
},
{
"exact_snippets": [
"≥ 5 days for antiplatelet agents"
],
"criterion": "antiplatelet agents",
"requirement_type": "holding duration",
"expected_value": {
"comparisons": [
{
"operator": ">=",
"value": 5
}
]
}
},
{
"exact_snippets": [
"≥ 5 days for",
"warfarin"
],
"criterion": "warfarin",
"requirement_type": "holding duration",
"expected_value": {
"comparisons": [
{
"operator": ">=",
"value": 5
}
]
}
},
{
"exact_snippets": [
"≥ 24 hours for low-molecular weight heparin formulations"
],
"criterion": "low-molecular weight heparin formulations",
"requirement_type": "holding duration",
"expected_value": {
"comparisons": [
{
"operator": ">=",
"value": 24
}
]
}
}
]
},
{
"line": "* Contraindications to general anesthesia",
"criterions": [
{
"exact_snippets": [
"Contraindications to general anesthesia"
],
"criterion": "general anesthesia",
"requirement_type": "contraindications",
"expected_value": true
}
]
}
],
"miscellaneous_lines": [],
"failed_inclusion": [],
"failed_exclusion": [],
"failed_miscellaneous": []
}